Cite
MLA Citation
Günter U Höglinger et al.. “Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial.” Lancet neurology, vol. 20, no. 3, 2021, pp. 182–192. http://access.bl.uk/ark:/81055/vdc_100122207925.0x000014